BRPI0515346A - associação de polimorfismos protéicos com doenças coronárias do coração - Google Patents

associação de polimorfismos protéicos com doenças coronárias do coração

Info

Publication number
BRPI0515346A
BRPI0515346A BRPI0515346-8A BRPI0515346A BRPI0515346A BR PI0515346 A BRPI0515346 A BR PI0515346A BR PI0515346 A BRPI0515346 A BR PI0515346A BR PI0515346 A BRPI0515346 A BR PI0515346A
Authority
BR
Brazil
Prior art keywords
heart disease
coronary heart
association
protein polymorphisms
protein
Prior art date
Application number
BRPI0515346-8A
Other languages
English (en)
Inventor
Detlef Kozian
Heinz Goegelein
Karl-Ernst Siegler
Martina Jacobs
Jean-Francois Deleuze
Sylvain Ricard
Sandrine Mace
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of BRPI0515346A publication Critical patent/BRPI0515346A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

ASSOCIAçãO DE POLIMORFISMOS PROTéICOS COM DOENçAS CORONáRIAS DO CORAçãO. A invenção se refere a métodos para identificar um aumento no risco de doença coronária do coração em um indivíduo, onde a presença de outro aminoácido que não ácido Glutamínico na posição 23 e/ou a presença de outro aminoácido que não Valina na posição 337 na proteína de Kir6.2 é determinada em uma amostra. Ademais, sondas, iniciadores, polipeptídios ou polinucleotídeos adequados para os ditos métodos são reivindicados.
BRPI0515346-8A 2004-09-10 2005-08-27 associação de polimorfismos protéicos com doenças coronárias do coração BRPI0515346A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04021528A EP1637612A1 (en) 2004-09-10 2004-09-10 Association of protein polymorphisms with coronary heart disease
PCT/EP2005/009270 WO2006027128A1 (en) 2004-09-10 2005-08-27 Association of protein polymorphisms with coronary heart disease

Publications (1)

Publication Number Publication Date
BRPI0515346A true BRPI0515346A (pt) 2008-07-22

Family

ID=34926489

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515346-8A BRPI0515346A (pt) 2004-09-10 2005-08-27 associação de polimorfismos protéicos com doenças coronárias do coração

Country Status (14)

Country Link
US (1) US20070292859A1 (pt)
EP (2) EP1637612A1 (pt)
JP (1) JP5376802B2 (pt)
KR (1) KR101232100B1 (pt)
CN (1) CN101018873B (pt)
AT (1) ATE447045T1 (pt)
AU (1) AU2005281927B2 (pt)
BR (1) BRPI0515346A (pt)
CA (1) CA2579885C (pt)
DE (1) DE602005017409D1 (pt)
DK (1) DK1791976T3 (pt)
IL (2) IL181554A (pt)
MX (1) MX2007002589A (pt)
WO (1) WO2006027128A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2698117C (en) 2007-04-26 2019-02-26 The Regents Of The University Of Michigan Fig4 gene mutations in neurodegeneration
US10907217B1 (en) * 2015-09-01 2021-02-02 Creighton University High resolution melt-curve analysis to identify the sequence type of E. coli

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US6027884A (en) * 1993-06-17 2000-02-22 The Research Foundation Of The State University Of New York Thermodynamics, design, and use of nucleic acid sequences
JP3661953B2 (ja) * 1995-09-18 2005-06-22 進 清野 新規なatp感受性のカリウムチャネル蛋白質とその遺伝子
GB9523497D0 (en) * 1995-11-16 1996-01-17 Ashcroft Frances Cell membrane protein and application thereof
AU2002347859A1 (en) * 2001-10-11 2003-04-22 Genacy System, method, and apparatus for submitting genetic samples and receiving genetic testing results anonymously
AU2003269993A1 (en) * 2002-08-22 2004-03-11 Deana A. Arnold Haplotype structures of chromosome 21
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof

Also Published As

Publication number Publication date
EP1637612A1 (en) 2006-03-22
KR101232100B1 (ko) 2013-02-12
IL181554A (en) 2012-05-31
AU2005281927A1 (en) 2006-03-16
IL211178A (en) 2012-08-30
AU2005281927B2 (en) 2011-12-01
WO2006027128A1 (en) 2006-03-16
HK1107709A1 (en) 2008-04-11
DE602005017409D1 (de) 2009-12-10
IL211178A0 (en) 2011-04-28
MX2007002589A (es) 2007-08-06
US20070292859A1 (en) 2007-12-20
JP2008512103A (ja) 2008-04-24
KR20070050473A (ko) 2007-05-15
IL181554A0 (en) 2007-07-04
EP1791976B1 (en) 2009-10-28
CN101018873A (zh) 2007-08-15
ATE447045T1 (de) 2009-11-15
CA2579885C (en) 2014-05-06
CA2579885A1 (en) 2006-03-16
EP1791976A1 (en) 2007-06-06
DK1791976T3 (da) 2010-03-08
CN101018873B (zh) 2011-11-02
JP5376802B2 (ja) 2013-12-25

Similar Documents

Publication Publication Date Title
DE60323231D1 (de) Verkürzte tau proteine
EP2287618A3 (en) Method for diagnosing neuro-degenerative disease
PT2332582E (pt) Activação de ace2 para o tratamento de doença cardíaca, pulmonar e renal e de hipertensão
EP2662453A3 (en) Detection and treatment of schizophrenia
WO2001000661A3 (en) Carnitine carrier related protein-1
ATE534909T1 (de) Verfahren zur proteomischen profilierung mithilfe nichtnatürlicher aminosäuren
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
IL211178A0 (en) Association of protein polymorphisms with coronary heart disease
EP1560025A3 (en) Specific markers for diabetes
WO2003046180A3 (en) Human cdnas and proteins and uses thereof
AR056125A1 (es) Procedimiento para el diagnostico de tromboembolias y cardiopatias isquemicas
ATE344325T1 (de) Neisseria lactoferrin-bindendes protein
WO2001077305A3 (en) Variants of the human amp-activated protein kinase gamma 3 subunit
ATE421693T1 (de) Proteine in der diabetes-proteomanalyse
WO2005019825A3 (en) Secreted polypeptide species and use thereof
DE60334200D1 (de) Verfahren zur messung von neprilysinaktivität
WO2003020911A3 (en) Human schizophrenia gene
WO2007022041A3 (en) Mutations and polymorphisms of hdac3
DE60023460D1 (de) Cdna von menschlicher methylentetrahydrofolatreduktase
DE602006004966D1 (de) Intrinsic-faktor vom schwein
WO2002075317A3 (en) Screening for drugs against disorders associated with schizophrenia
WO2000056922A3 (en) Genetic polymorphism and polymorphic pattern for assessing disease status, and compositions for use thereof
WO2004074446A3 (en) Parkin interacting polypeptides and methods of use
ATE417936T1 (de) Verfahren zur bestimmung des allelischen zustandes am 5'-ende des alpha-s1-kaseingens
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2158 DE 15/05/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements